{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:34Z","timestamp":1786119694578,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/spc.0b013e3283437a39","type":"journal-article","created":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T00:55:54Z","timestamp":1295484954000},"page":"15-19","source":"Crossref","is-referenced-by-count":25,"title":["Transdermal opioids for cancer pain"],"prefix":"10.1097","volume":"5","author":[{"given":"Elaine","family":"Cachia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam H","family":"Ahmedzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20211004","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJM199403033300902","article-title":"Pain and its treatment in outpatients with metastatic cancer","volume":"330","author":"Cleeland","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-4-20211004","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40 years","volume":"18","author":"van den Beuken-van Everdingen","year":"2007","journal-title":"Ann Oncol"},{"key":"R3-4-20211004","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"},{"key":"R4-4-20211004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/bjaceaccp\/mkm033","article-title":"Transdermal drug delivery: principles and opioid therapy","volume":"7","author":"Margetts","year":"2007","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"R5-4-20211004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1567201052772915","article-title":"Transdermal drug delivery: penetration enhancement techniques","volume":"2","author":"Benson","year":"2005","journal-title":"Curr Drug Deliv"},{"issue":"Suppl 3","key":"R6-4-20211004","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00001813-199504003-00009","article-title":"Guidelines for the clinical use of transdermal fentanyl","volume":"6","author":"Payne","year":"1995","journal-title":"Anticancer Drugs"},{"key":"R8-4-20211004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpainsymman.2004.07.005","article-title":"Buprenorphine: considerations for pain management","volume":"29","author":"Johnson","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R9-4-20211004","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejpain.2008.04.011","article-title":"Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine","volume":"13","author":"Kress","year":"2009","journal-title":"Eur J Pain"},{"key":"R10-4-20211004","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0196-9781(00)00252-7","article-title":"Agonistic effects of the opioid buprenorphine on the nociceptin\/OFQ receptor","volume":"21","author":"Bloms-Funke","year":"2000","journal-title":"Peptides"},{"key":"R11-4-20211004","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/bja\/ael051","article-title":"Buprenorphine induces ceiling in respiratory depression but not in analgesia","volume":"96","author":"Dahan","year":"2006","journal-title":"Br J Anaesth"},{"key":"R15-4-20211004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/JPR.S6503","article-title":"Transdermal buprenorphine: a critical appraisal of its role in pain management","volume":"2","author":"Hans","year":"2009","journal-title":"J Pain Res"},{"key":"R16-4-20211004","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejpain.2005.12.001","article-title":"Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine","volume":"10","author":"Filitz","year":"2006","journal-title":"Eur J Pain"},{"key":"R17-4-20211004","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0149-2918(03)90019-1","article-title":"Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"25","author":"Sittl","year":"2003","journal-title":"Clin Ther"},{"key":"R18-4-20211004","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.clinthera.2004.11.008","article-title":"Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study","volume":"26","author":"Sorge","year":"2004","journal-title":"Clin Ther"},{"key":"R19-4-20211004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1163\/156856903321579334","article-title":"Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS) in the treatment of patients with chronic pain. A randomized, double-blind, placebo-controlled study","volume":"15","author":"B\u00f6hme","year":"2003","journal-title":"Pain Clinic"},{"key":"R20-4-20211004","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.clinthera.2006.06.012","article-title":"Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials","volume":"28","author":"Likar","year":"2006","journal-title":"Clin Ther"},{"key":"R21-4-20211004","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2741\/2147","article-title":"Buprenorphine in long-term control of chronic pain in cancer patients","volume":"12","author":"Pace","year":"2007","journal-title":"Front Biosci"},{"key":"R22-4-20211004","first-page":"707","article-title":"Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review","volume":"5","author":"Deandrea","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"R23-4-20211004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jpainsymman.2005.03.015","article-title":"Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: a prospective, multicenter pilot study in outpatients with chronic pain","volume":"30","author":"Freynhagen","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R24-4-20211004","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1089\/jpm.2009.0051","article-title":"The role of fentanyl in cancer-related pain","volume":"12","author":"Prommer","year":"2009","journal-title":"J Palliat Med"},{"key":"R25-4-20211004","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jpainsymman.2007.10.023","article-title":"A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain","volume":"36","author":"Kress","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"R26-4-20211004","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pain.2009.04.012","article-title":"Transdermal fentanyl in cachectic cancer patients","volume":"144","author":"Heiskanen","year":"2009","journal-title":"Pain"},{"key":"R27-4-20211004","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0885-3924(97)00082-1","article-title":"Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group","volume":"13","author":"Ahmedzai","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"R28-4-20211004","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1185\/030079904X2114","article-title":"Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic noncancer pain","volume":"20","author":"Clark","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"R29-4-20211004","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/jpm.2007.0200","article-title":"Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature","volume":"11","author":"Tassinari","year":"2008","journal-title":"J Palliat Med"},{"key":"R30-4-20211004","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/082585970902500304","article-title":"Transdermal fentanyl as a front-line approach to moderate-severe pain: a meta-analysis of randomized clinical trials","volume":"25","author":"Tassinari","year":"2009","journal-title":"J Palliat Care"},{"key":"R31-4-20211004","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpainsymman.2007.03.015","article-title":"Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety","volume":"35","author":"Noble","year":"2008","journal-title":"J Pain Symptom Manage"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01263393-201103000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:46:05Z","timestamp":1786041965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01263393-201103000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0b013e3283437a39","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}